Quell Therapeutics Appoints Experienced Biopharma Leader Luke Beshar as Independent Chair of its Board of Directors Quell Therapeutics Appoints Experienced Biopharma Leader Luke Beshar as Independent Chair of its Board of Directors Luke brings more than 35 years of experience to the role, and has been non-executive director of a range of large biopharmaceutical companies etherna appoints Antonin de Fougerolles as new Chairperson etherna appoints Antonin de Fougerolles as new Chairperson Tony has extensive experience in the development of novel therapeutic modalities, such as RNAis and modified mRNAs for vaccinations Selkirk Pharma appoints Colleen Dixon as CEO Selkirk Pharma appoints Colleen Dixon as CEO Colleen has more than 30 years of experience in the pharmaceutical industry, and will succeed Patrick Haffey Newcells Biotech appoints Emile Shaffu as Director of Sales Newcells Biotech appoints Emile Shaffu as Director of Sales Emile will work with Newcells to expand its global presence, as well as boost its customer service capabilities H.E.L Group appoints Yih-Shing Duh as Chief Scientific Advisor H.E.L Group appoints Yih-Shing Duh as Chief Scientific Advisor Prof. Duh will continue to assist H.E.L Group in developing its battery calorimeters and lithium ion battery testing protocols Lonza appoints Wolfgang Wienand as the group’s CEO Lonza appoints Wolfgang Wienand as the group’s CEO Wolfgang will lead Lonza as the CDMO continues to push its growth and customer satisfaction Marchesini Group appoints President Maurizio Marchesini as CEO Marchesini Group appoints President Maurizio Marchesini as CEO President Marchesini will focus on investing in technological advances in pharmaceutical manufacturing, as well as globalisation for the group Asymchem appoints Dr Cheng Yi Chen as CTO of Small Molecules Asymchem appoints Dr Cheng Yi Chen as CTO of Small Molecules He will support the group's small molecule sales and offer technical guidance to laboratories and pilot production sites across Europe CN Bio appoints Lydia Seymour as VP of People and Culture CN Bio appoints Lydia Seymour as VP of People and Culture Lydia will work to enhance the company's workplace culture, whilst also supporting the career development and general wellbeing of employees Actylis appoints Scott Thomson as CEO Actylis appoints Scott Thomson as CEO Scott will endeavour to globally expand the company's integrated manufacturing and sourcing strategy Enterprise Therapeutics appoints new as Chief Medical Officer and Non-Executive Director Enterprise Therapeutics appoints new as Chief Medical Officer and Non-Executive Director The appointments will help push the company's lead asset through Phase II trials Onyx Scientific aims for European growth with new BD hire Onyx Scientific aims for European growth with new BD hire Leading small molecule CDMO Onyx Scientific has its sights set on European-wide commercial expansion with the new appointment of Courtnie Thomas Wilks as Business Development... AES Clean Technology appoints Chris Miller as CEO AES Clean Technology appoints Chris Miller as CEO Miller will champion the company’s growth whilst encouraging the development of industry innovations Asymchem hires Franck Mevellec as Senior Director of business development Asymchem hires Franck Mevellec as Senior Director of business development Franck has more than 20 years of industry experience, holding key positions in sales, R&D and portfolio management Exonate appoints Dr Rafiq Hasan as Non-Executive Director Exonate appoints Dr Rafiq Hasan as Non-Executive Director Dr Hasan will assist the company in developing its lead candidate, as well as strengthening its commercial strategy Rentschler Biopharma appoints Patrick Meyer as Global Head BD Sales and Alliance Management Rentschler Biopharma appoints Patrick Meyer as Global Head BD Sales and Alliance Management Rentschler Biopharma SE announces that Patrick Meyer, Ph.D., has been promoted to Global Head BD Sales and Alliance Management within the business development team, effective...